GTIV

Heed the Red Flags at Amedisys

Congressional scrutiny of home health care specialist Amedisys, along with lowered guidance, are sure-fire signs that investors should proceed with care. More

ADVERTISEMENT
- Most Popular
- Most Commented
Does Alcatel-Lucent Have a Cisco Killer?Sapp Files for Bankruptcy, Lists 200+ Pairs of Jordans as Assets 2008 TARP Funds -- Where Are They Now?HP’s Latest Turnaround Doomed to Fail - Just Like the Rest Woman Wins Lottery Twice in One Day Top 10 Dow Dividend Stocks for May

Does Alcatel-Lucent Have a Cisco Killer?Broadcasters Sue Dish Over Ad-Skipping DVR 10 Companies Piling on the CEO Perks 7 Industrial Stocks Manufactured to Sell 10 Companies Increasing Dividends 7 Diseases Back From The Past
Editor's Picks
Poll of the Day
Partners
ADVERTISEMENT

GTIV

Recent Articles

Heed the Red Flags at Amedisys

More InvestorPlace Features